Edition:
India

Nightstar Therapeutics PLC (NITE.OQ)

NITE.OQ on NASDAQ Stock Exchange Global Select Market

14.62USD
1:30am IST
Change (% chg)

$0.19 (+1.32%)
Prev Close
$14.43
Open
$14.62
Day's High
$14.62
Day's Low
$14.54
Volume
3,064
Avg. Vol
8,038
52-wk High
$24.70
52-wk Low
$10.01

Chart for

About

Nightstar Therapeutics PLC, formerly Nightstar Therapeutics Limited, is a clinical-stage gene therapy company. The Company is focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness. The Company is developing a... (more)

Overall

Beta: --
Market Cap(Mil.): $470.69
Shares Outstanding(Mil.): 28.10
Dividend: --
Yield (%): --

Financials

BRIEF-Nightstar Therapeutics Starts Star Phase 3 Registrational Trial For Nsr-Rep1 In Choroideremia

* NIGHTSTAR THERAPEUTICS ANNOUNCES INITIATION OF STAR PHASE 3 REGISTRATIONAL TRIAL FOR NSR-REP1 IN CHOROIDEREMIA

05 Mar 2018

Earnings vs. Estimates